Company / Free Cash Flow
UTAH MEDICAL PRODUCTS INC Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$21.6M
FY2025
5-year range
$16.5M / $21.6M
FY2021-FY2025
Trend
+6.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 10 years, ranging from $11M in FY2018 to $22M in FY2025.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +5.7%.
Improved from $21M to $22M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +3.9%
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +5.7%, indicating consistent growth.
- In FY2025, free cash flow increased 6.4% year-over-year.
- Lowest free cash flow in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.6M | +6.4% |
| FY2024 | $20.3M | -1.5% |
| FY2023 | $20.7M | +7.1% |
| FY2022 | $19.3M | +16.7% |
| FY2021 | $16.5M | +0.5% |
| FY2020 | $16.4M | +7.3% |
| FY2019 | $15.3M | +36.3% |
| FY2018 | $11.2M | -17.5% |
| FY2017 | $13.6M | -4.6% |
| FY2016 | $14.3M | +19.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026